SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 15% Stake in Exact Sciences Corp
Beneficial Ownership Report
FMR LLC and its Chairman and CEO, Abigail P. Johnson, have filed an amended Schedule 13G, disclosing a combined beneficial ownership of 15.0% of Exact Sciences Corp's common stock as of March 31, 2025.
Summary
- FMR LLC and Abigail P. Johnson, as reporting persons, have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Exact Sciences Corp.
- As of March 31, 2025, the aggregate amount beneficially owned by each reporting person is 27,899,650.54 shares of common stock.
- This represents 15.0% of the class of common stock of Exact Sciences Corp.
- FMR LLC holds sole voting power over 27,530,918.06 shares and sole dispositive power over 27,899,650.54 shares.
- Abigail P. Johnson, through her role as Director, Chairman, and Chief Executive Officer of FMR LLC and the Johnson family's control of FMR LLC, is deemed to beneficially own the same aggregate amount of shares with sole dispositive power.
- The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 6
Explanation: The document is a factual disclosure of beneficial ownership by a major institutional investor. While the disclosure itself is neutral, the presence of a significant stake (15.0%) by FMR LLC in Exact Sciences Corp could be viewed as a positive signal by the market, indicating institutional confidence.
Positives
- The disclosure of a significant 15.0% stake by a major institutional investor like FMR LLC can be interpreted as a vote of confidence in Exact Sciences Corp.
- The filing explicitly states that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control, which suggests a long-term investment perspective rather than activist intent.
Future Outlook
NA
Management Comments
- "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ยงยง 240.14a-11."
Industry Context
This filing is a standard disclosure of a significant passive investment by a large asset manager in a publicly traded company. It does not provide specific industry context for Exact Sciences Corp beyond the fact that it is a publicly traded entity.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by FMR LLC may influence investor perception and potentially the stock price, signaling confidence from a major investment firm.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires filing of this statement (reporting date for beneficial ownership) |
| 05/09/2025 | Date of filing of the Schedule 13G Amendment No. 1 |
Keywords
Exact Sciences Corp, FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, common stock, institutional investment, SEC filing, ownership disclosure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.